Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Plerixafor may help restore skin pigmentation safely.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

QR678 Neo is more effective than PRP for hair growth and quality.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

A woman's hair grew back after she stopped taking the Parkinson's disease medication pramipexole.

Red-light therapy may slow myopia progression better than traditional treatments.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

PDRN from trout sperm helps skin and hair regeneration but is costly and complex to produce.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

PRP shows promise for spinal pain but needs more guidelines before widespread use.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

A new drug strategy improves hair loss treatment with better results and safety.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

PPARs help regulate skin health and could be used to treat skin disorders.

Ritlecitinib shows promise in improving severe alopecia areata, with 27% of patients seeing success.

PRP is a safe natural treatment that improves skin by reducing wrinkles and enhancing texture for up to 4 months.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.